Sharda Cropchem Limited has informed the Exchange about Investor Presentation
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharda Cropchem reported strong Q1 FY26 results with consolidated revenue up 25% YoY to Rs. 985 crore, driven by 13% volume growth led by Europe. Agrochemical revenue grew 25% to Rs. 846 crore, while non-agrochemical jumped 31% to Rs. 139 crore. Gross margins expanded sharply by 630 basis points to 35.5%, lifting EBITDA by 67% to Rs. 142 crore (margin 14.4%) and PAT more than 4x to Rs. 143 crore (margin 14.5%), aided by a Rs. 73 crore forex gain. Europe surged 43% in agrochemical sales, while RoW declined 20%. The company holds 2,981 product registrations (1,021 pending), operates in 80+ countries with 525+ distributors, and has a strong balance sheet with Rs. 791 crore in cash and liquid investments, zero debt, and a 16% RoCE.
Strong beat on margins and profits — the company is guiding gross margins to sustain around 35.5% in FY26, which is a meaningful upgrade versus FY25's 29.9%. This is likely to be viewed positively by the market, though a large part of the PAT surge is forex-driven and may not repeat.